Loading clinical trials...
Loading clinical trials...
Evaluation of Efficacy and Safety of Oral Roflumilast in Treatment of Moderate to Severe Psoriasis: a Pilot Study
Conditions
Interventions
Oral roflumilast
Locations
1
Egypt
Mansoura University Hospital
Al Mansurah, Dakahlia Governorate, Egypt
Start Date
August 20, 2025
Primary Completion Date
February 28, 2026
Completion Date
February 28, 2026
Last Updated
December 2, 2025
NCT06982352
NCT06592274
NCT07169019
NCT07021495
NCT06987292
NCT06937060
Ahmed Ibrahim Ali, Master degree of Dermatology
CONTACT
+201011442104Ahmed.abdelhadi@med.suezuni.edu.egLead Sponsor
Ahmed Ibrahim
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions